123 related articles for article (PubMed ID: 37608419)
41. The Postoperative outcomes of thoracoscopic-laparoscopic Ivor-Lewis surgery plus D2 celiac lymphadenectomy for patients with adenocarcinoma of the esophagogastric junction.
Li KK; Bao T; Wang YJ; Liu XH; Guo W
Surg Endosc; 2020 Nov; 34(11):4957-4966. PubMed ID: 31823049
[TBL] [Abstract][Full Text] [Related]
42. A minimally invasive abdominal and left thoracic approach as a palliative treatment for adenocarcinoma of the esophagogastric junction with severe stenosis: A case report.
Takeuchi Y; Ebihara Y; Nakanishi Y; Asano T; Noji T; Kurashima Y; Murakami S; Nakamura T; Tsuchikawa T; Okamura K; Shichinohe T; Hirano S
Asian J Endosc Surg; 2020 Apr; 13(2):215-218. PubMed ID: 31240864
[TBL] [Abstract][Full Text] [Related]
43. Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial.
Zhang X; Liang H; Li Z; Xue Y; Wang Y; Zhou Z; Yu J; Bu Z; Chen L; Du Y; Wang X; Wu A; Li G; Su X; Xiao G; Cui M; Wu D; Chen L; Wu X; Zhou Y; Zhang L; Dang C; He Y; Zhang Z; Sun Y; Li Y; Chen H; Bai Y; Qi C; Yu P; Zhu G; Suo J; Jia B; Li L; Huang C; Li F; Ye Y; Xu H; Wang X; Yuan Y; E JY; Ying X; Yao C; Shen L; Ji J;
Lancet Oncol; 2021 Aug; 22(8):1081-1092. PubMed ID: 34252374
[TBL] [Abstract][Full Text] [Related]
44. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
[TBL] [Abstract][Full Text] [Related]
45. [Short-term efficacy and safety of the synchronous neoadjuvant chemoradiotherapy with paclitaxel plus carboplatin in stage III adenocarcinoma of esophagogastric junction].
Ji Y; Peng T; Wang G; Zhang Y; Cao M; Gao Q; Li S
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1019-1024. PubMed ID: 30269322
[TBL] [Abstract][Full Text] [Related]
46. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
47. FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal-gastric junction.
Fencl P; Belohlavek O; Harustiak T; Zemanova M
Abdom Radiol (NY); 2016 Nov; 41(11):2089-2094. PubMed ID: 27405645
[TBL] [Abstract][Full Text] [Related]
48. [Application of artificial pneumothorax in semi-prone position to the video-assisted thoracic surgery of esophageal carcinoma].
Peng L; Han YT; Wang X; Xiao WG; Chen LH
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):785-9. PubMed ID: 23291075
[TBL] [Abstract][Full Text] [Related]
49. [Pathological Complete Response in a Case of Advanced Gastric Cancer with Para-Aortic Lymph Nodes Metastasis Treated by Preoperative Chemotherapy with S-1 and Oxaliplatin(SOX Therapy)].
Noro H; Hirao T; Takayama K; Hara S; Yoshida M; Yoneda K; Ohashi T; Osawa H; Sakai K; Ide Y; Iwasaki T; Hatanaka N; Yamasaki Y; Yoshida Y
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2278-2280. PubMed ID: 33468933
[TBL] [Abstract][Full Text] [Related]
50. Sentinel node mapping in adenocarcinoma of the esophagogastric junction.
Matsuda T; Takeuchi H; Tsuwano S; Nakahara T; Mukai M; Kitagawa Y
World J Surg; 2014 Sep; 38(9):2337-44. PubMed ID: 24752362
[TBL] [Abstract][Full Text] [Related]
51. Significance of lymph nodal metastases in treatment of esophagogastric adenocarcinoma.
Aikou T; Shimazu H; Takao T; Baba M; Natsugoe S; Simada M
Lymphology; 1992 Mar; 25(1):31-6. PubMed ID: 1569781
[TBL] [Abstract][Full Text] [Related]
52. Current trends in the surgical treatment of esophageal and cardia adenocarcinoma.
Peracchia A; Bonavina L; Via A; Incarbone R
J Exp Clin Cancer Res; 1999 Sep; 18(3):289-94. PubMed ID: 10606171
[TBL] [Abstract][Full Text] [Related]
53. Clinical outcomes and benefits for staging of surgical lymph node mapping after esophagectomy.
Lagarde SM; Phillips AW; Navidi M; Disep B; Griffin SM
Dis Esophagus; 2017 Dec; 30(12):1-7. PubMed ID: 28881884
[TBL] [Abstract][Full Text] [Related]
54. [Curative Resection for Advanced Gastric Cancer with Lymph Node Metastasis along the Middle Colic Artery].
Namikawa T; Shimizu S; Maeda M; Yokota K; Tanioka N; Munekage M; Uemura S; Maeda H; Kitagawa H; Kumon T; Kumon M; Kobayashi M; Hanazaki K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1564-1566. PubMed ID: 35046257
[TBL] [Abstract][Full Text] [Related]
55. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
[TBL] [Abstract][Full Text] [Related]
56. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
57. Surgical treatment strategy for esophagogastric junction cancers based on the tumor diameter.
Hoshino I; Gunji H; Ishige F; Iwatate Y; Takiguchi N; Ikeda A; Soda H; Tonooka T; Sato N; Kawahara K; Nabeya Y
BMC Surg; 2019 Oct; 19(1):152. PubMed ID: 31651313
[TBL] [Abstract][Full Text] [Related]
58. [Prognostic significance of the number of dissected lymph nodes in Siewert type Ⅱadenocarcinoma of the esophagogastric junction without lymphatic metastasis].
Wang JQ; Wei DZ; Xie MR; Xu SB; Ma DC
Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):300-4. PubMed ID: 27087378
[TBL] [Abstract][Full Text] [Related]
59. [A Case of Long-Term Disease Control after Administration of Oxaliplatin for Esophagogastric Junction Squamous Cell Carcinoma].
Minami S; Motoori M; Miyazaki Y; Nishizawa Y; Komatsu H; Inoue A; Tomokuni A; Komori T; Fujitani K; Iwase K
Gan To Kagaku Ryoho; 2020 Feb; 47(2):310-312. PubMed ID: 32381972
[TBL] [Abstract][Full Text] [Related]
60. [A case of mixed adenoneuroendocrine carcinoma of the esophagogastric junction treated with neoadjuvant chemotherapy].
Nakai M; Kawasaki H; Wajima N; Kimura A; Nakayama Y; Muroya T; Yonaiyama S; Okano K; Nagase H; Hakamada K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2301-3. PubMed ID: 24394092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
